This inventor holds 8 USPTO granted patents, plus 4 CIPO patents and 2 EPO patents. Top assignees: Ed. Geistlich Soehne Ag Fuer Chemische Industrie, Geistlich Pharma Ag. Active years: 2003-2020.
Location History:
- Wilton, IE (2003 - 2011)
- Cork, IE (2008 - 2015)
- Wilton Cork, IE (2020)
Company Filing History:
7 out of 30 
1 out of 35 Years Active: 2003-2020
Title: The Innovative Mind of H Paul Redmond
Introduction
H Paul Redmond, an accomplished inventor based in Cork, Ireland, has made significant contributions to the field of medical innovations. With a total of eight patents to his name, Redmond has focused primarily on developing treatments for serious health conditions, particularly cancer. His groundbreaking work reflects his dedication to improving patient outcomes through innovative medical therapies.
Latest Patents
Among his latest patents is a method for treating triple-negative breast cancer (TNBC). This innovative approach involves a multidisciplinary treatment regimen that combines various therapies such as checkpoint inhibitors, hyperthermia treatment, low-dose chemotherapy, Interleukin-2 (IL-2), and specific compounds including taurolidine and taurultam. This comprehensive method represents a significant advancement in the battle against one of the most challenging forms of breast cancer.
Another noteworthy patent addresses the enhancement of the effectiveness of 5-Fluorouracil in treating tumor metastases and cancer. Redmond's combination therapy, which includes effective amounts of 5-Fluorouracil and a methylol transfer agent like taurolidine, demonstrates promising results in inhibiting tumor growth and metastases, further showcasing his innovative contributions to cancer treatment.
Career Highlights
Throughout his career, H Paul Redmond has worked with esteemed companies such as Ed. Geistlich Soehne AG Für Chemische Industrie and Geistlich Pharma AG. His roles in these organizations have allowed him to collaborate with other leading professionals in the medical field, facilitating the development of crucial therapeutic innovations that have the potential to save lives.
Collaborations
One of Redmond's notable collaborations has been with Rolf Wilhelm Pfirrmann. Together, they have shared insights and expertise, which have enriched the research and development processes in their respective fields. Their partnership exemplifies the power of collaboration in advancing medical technology and treatment methodologies.
Conclusion
H Paul Redmond's innovative spirit and commitment to cancer research have positioned him as a significant figure in the medical invention landscape. With his notable patents and impactful collaborations, he continues to pave the way for advancements in cancer treatment, offering hope to patients and the medical community alike. His work not only reflects creativity and determination but also a deep commitment to improving health outcomes through innovation.